Published in Proc Natl Acad Sci U S A on September 02, 2005
Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol (2008) 4.31
Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol (2009) 2.59
Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol (1985) (2009) 1.76
Arginase and vascular aging. J Appl Physiol (1985) (2008) 1.33
Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans. Hypertension (2011) 1.15
Evolution of the arginase fold and functional diversity. Cell Mol Life Sci (2008) 1.09
Secondary amines containing one aromatic nitro group: preparation, nitrosation, sustained nitric oxide release, and the synergistic effects of released nitric oxide and an arginase inhibitor on vascular smooth muscle cell proliferation. Bioorg Med Chem (2013) 1.07
Crystal structure of human arginase I complexed with thiosemicarbazide reveals an unusual thiocarbonyl mu-sulfide ligand in the binuclear manganese cluster. J Am Chem Soc (2007) 1.07
Role of arginase 1 from myeloid cells in th2-dominated lung inflammation. PLoS One (2013) 1.02
Expression, purification, assay, and crystal structure of perdeuterated human arginase I. Arch Biochem Biophys (2007) 0.98
Inhibition of human arginase I by substrate and product analogues. Arch Biochem Biophys (2010) 0.97
Probing the specificity determinants of amino acid recognition by arginase. Biochemistry (2009) 0.97
Arginase: an old enzyme with new tricks. Trends Pharmacol Sci (2015) 0.94
2-aminoimidazole amino acids as inhibitors of the binuclear manganese metalloenzyme human arginase I. J Med Chem (2010) 0.93
Crystal structure of arginase from Plasmodium falciparum and implications for L-arginine depletion in malarial infection . Biochemistry (2010) 0.92
Mechanism for the hydrolysis of a sulfur-sulfur bond based on the crystal structure of the thiosulfohydrolase SoxB. J Biol Chem (2009) 0.90
Development of novel arginase inhibitors for therapy of endothelial dysfunction. Front Immunol (2013) 0.89
Inhibition profile of Leishmania mexicana arginase reveals differences with human arginase I. Int J Parasitol (2011) 0.88
Binding of α,α-disubstituted amino acids to arginase suggests new avenues for inhibitor design. J Med Chem (2011) 0.88
Crystal structures of complexes with cobalt-reconstituted human arginase I. Biochemistry (2011) 0.86
Computational investigation of the oxidative deboronation of boroglycine, H2N-CH2-B(OH)2, Using H2O and H2O2. J Phys Chem A (2009) 0.86
Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections. Arch Biochem Biophys (2013) 0.83
Schistosoma mansoni arginase shares functional similarities with human orthologs but depends upon disulphide bridges for enzymatic activity. Int J Parasitol (2008) 0.82
Crystal structure of Schistosoma mansoni arginase, a potential drug target for the treatment of schistosomiasis. Biochemistry (2014) 0.80
Crystallization of an apo form of human arginase: using all the tools in the toolbox simultaneously. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.79
Structure and function of non-native metal clusters in human arginase I. Biochemistry (2012) 0.77
Synthesis of (2S)-2-amino-7,8-epoxyoctanoic acid and structure of its metal-bridging complex with human arginase I. Org Biomol Chem (2008) 0.77
Synthesis of a new trifluoromethylketone analogue of l-arginine and contrasting inhibitory activity against human arginase I and histone deacetylase 8. Bioorg Med Chem Lett (2011) 0.77
Arginine deficiency augments inflammatory mediator production by airway epithelial cells in vitro. Respir Res (2009) 0.77
Chronic oral administration of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) improves erectile function in aged rats. J Androl (2012) 0.77
Crystal structure of an arginase-like protein from Trypanosoma brucei that evolved without a binuclear manganese cluster. Biochemistry (2014) 0.76
Formiminoglutamase from Trypanosoma cruzi is an arginase-like manganese metalloenzyme. Biochemistry (2013) 0.76
Expression, purification and characterization of arginase from Helicobacter pylori in its apo form. PLoS One (2011) 0.76
Impact of substrate protonation and tautomerization states on interactions with the active site of arginase I. J Chem Inf Model (2013) 0.75
Arginase of Helicobacter Gastric Pathogens Uses a Unique Set of Non-catalytic Residues for Catalysis. Biophys J (2017) 0.75
Binding of the unreactive substrate analog L-2-amino-3-guanidinopropionic acid (dinor-L-arginine) to human arginase I. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.75
Metal ion-mediated reduction in surface entropy improves diffraction quality of crystals of the IRAK-4 death domain. J Biomol Tech (2006) 0.75
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
SHELXL: high-resolution refinement. Methods Enzymol (1997) 43.04
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res (2005) 6.66
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res (2004) 4.74
Detecting and overcoming crystal twinning. Methods Enzymol (1997) 4.35
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest (2003) 4.08
Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol (1995) 3.17
L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol (2003) 2.91
Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr (2002) 2.70
Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem (2002) 2.62
Structure of a unique binuclear manganese cluster in arginase. Nature (1996) 2.34
Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med (2004) 2.01
Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun (1995) 1.89
Mechanistic basis of enzyme-targeted drugs. Biochemistry (2005) 1.71
Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res (2001) 1.62
Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun (1995) 1.57
Arginase: structure, mechanism, and physiological role in male and female sexual arousal. Acc Chem Res (2005) 1.52
Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum. Biochemistry (2001) 1.51
Arginase-boronic acid complex highlights a physiological role in erectile function. Nat Struct Biol (1999) 1.48
Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res (2000) 1.46
Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. Am J Physiol Lung Cell Mol Physiol (2003) 1.44
Refined solution structure of the LpxC-TU-514 complex and pKa analysis of an active site histidine: insights into the mechanism and inhibitor design. Biochemistry (2005) 1.40
Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity. J Immunol (1995) 1.36
UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase functions through a general acid-base catalyst pair mechanism. J Biol Chem (2005) 1.32
Human arginase II: crystal structure and physiological role in male and female sexual arousal. Biochemistry (2003) 1.30
Molecular cloning and nucleotide sequence of cDNA for human liver arginase. Proc Natl Acad Sci U S A (1987) 1.24
Structure determination of plastocyanin from a specimen with a hemihedral twinning fraction of one-half. Acta Crystallogr D Biol Crystallogr (1993) 1.20
Role of ornithine as a proline precursor in healing wounds. J Surg Res (1993) 1.16
Arginase and autoimmune inflammation in the central nervous system. Immunology (2003) 1.15
A rapid and sensitive assay for arginase. Anal Biochem (1980) 1.13
Classical and slow-binding inhibitors of human type II arginase. Biochemistry (2001) 1.12
The interaction of macrophages and bacteria: a comparative study of the induction of tumoricidal activity and of reactive nitrogen intermediates. Cell Immunol (1991) 1.06
Structural and functional importance of first-shell metal ligands in the binuclear manganese cluster of arginase I. Biochemistry (2003) 1.04
Mutagenesis of rat liver arginase expressed in Escherichia coli: role of conserved histidines. Biochemistry (1994) 1.03
Arginase: a binuclear manganese metalloenzyme. Met Ions Biol Syst (2000) 1.01
Loss of function mutations in conserved regions of the human arginase I gene. Biochem Mol Med (1996) 0.97
Implications of the S-shaped domain in the quaternary structure of human arginase. Biochim Biophys Acta (2000) 0.90
Clinical significance of arginase in colorectal cancer. Cancer (1992) 0.84
A new chromophoric assay for arginase activity. Anal Biochem (1999) 0.83
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res (2005) 6.66
A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science (2008) 5.28
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res (2004) 4.74
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev (2008) 4.40
Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res (2009) 4.16
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med (2005) 3.80
Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res (2007) 3.66
L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood (2006) 3.17
HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle. Nature (2012) 3.08
Essential role of PDK1 in regulating cell size and development in mice. EMBO J (2002) 2.93
L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol (2003) 2.91
Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res (2008) 2.70
Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science (2008) 2.67
Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem (2002) 2.62
Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res (2007) 2.62
Bornyl diphosphate synthase: structure and strategy for carbocation manipulation by a terpenoid cyclase. Proc Natl Acad Sci U S A (2002) 2.44
Prevention of steatosis by hepatic JNK1. Cell Metab (2009) 2.20
Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res (2009) 1.99
BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo. J Biol Chem (2005) 1.95
p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J (2005) 1.90
Induction of hepatitis by JNK-mediated expression of TNF-alpha. Cell (2009) 1.79
Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol (1985) (2009) 1.76
Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors. Biochemistry (2008) 1.68
Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis. J Immunol (2010) 1.67
Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis. Biochemistry (2004) 1.59
Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways. Gastroenterology (2012) 1.58
Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment. J Infect Dis (2006) 1.53
Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis. Proc Natl Acad Sci U S A (2003) 1.52
Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis. Blood (2011) 1.50
Pentalenene synthase. Analysis of active site residues by site-directed mutagenesis. J Am Chem Soc (2002) 1.50
X-ray crystal structure of aristolochene synthase from Aspergillus terreus and evolution of templates for the cyclization of farnesyl diphosphate. Biochemistry (2007) 1.49
Taxadiene synthase structure and evolution of modular architecture in terpene biosynthesis. Nature (2010) 1.49
L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell Immunol (2005) 1.45
Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives. Immunol Invest (2012) 1.43
Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). J Immunol (2004) 1.37
Design of amino acid sulfonamides as transition-state analogue inhibitors of arginase. J Am Chem Soc (2003) 1.37
Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1. Genes Dev (2010) 1.36
Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer (2005) 1.35
Trinuclear Metal Clusters in Catalysis by Terpenoid Synthases. Pure Appl Chem (2010) 1.35
Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes. Curr Opin Struct Biol (2011) 1.35
Crystal structure of human liver Delta4-3-ketosteroid 5beta-reductase (AKR1D1) and implications for substrate binding and catalysis. J Biol Chem (2008) 1.34
Structure and mechanism of the diterpene cyclase ent-copalyl diphosphate synthase. Nat Chem Biol (2011) 1.33
Arginase and vascular aging. J Appl Physiol (1985) (2008) 1.33
UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase functions through a general acid-base catalyst pair mechanism. J Biol Chem (2005) 1.32
Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids. Protein Sci (2005) 1.32
X-ray crystal structures of D100E trichodiene synthase and its pyrophosphate complex reveal the basis for terpene product diversity. Biochemistry (2002) 1.31
Human arginase II: crystal structure and physiological role in male and female sexual arousal. Biochemistry (2003) 1.30
Nuclear localization of p38 MAPK in response to DNA damage. Int J Biol Sci (2009) 1.29
Structure of epi-isozizaene synthase from Streptomyces coelicolor A3(2), a platform for new terpenoid cyclization templates. Biochemistry (2010) 1.27
Structural basis of the antiproliferative activity of largazole, a depsipeptide inhibitor of the histone deacetylases. J Am Chem Soc (2011) 1.26
Mechanistic inferences from the binding of ligands to LpxC, a metal-dependent deacetylase. Biochemistry (2006) 1.25
Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance. Hum Mol Genet (2014) 1.25
Molecular recognition of the substrate diphosphate group governs product diversity in trichodiene synthase mutants. Biochemistry (2005) 1.20
Crystal structure of (+)-delta-cadinene synthase from Gossypium arboreum and evolutionary divergence of metal binding motifs for catalysis. Biochemistry (2009) 1.19
Exploring biosynthetic diversity with trichodiene synthase. Arch Biochem Biophys (2007) 1.18
Cryptophane xenon-129 nuclear magnetic resonance biosensors targeting human carbonic anhydrase. J Am Chem Soc (2009) 1.17
Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood (2010) 1.17
Purification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily. Eur J Biochem (2004) 1.16
T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress. Semin Cancer Biol (2005) 1.16
Stress- and mitogen-induced phosphorylation of the synapse-associated protein SAP90/PSD-95 by activation of SAPK3/p38gamma and ERK1/ERK2. Biochem J (2004) 1.16
Arginase and autoimmune inflammation in the central nervous system. Immunology (2003) 1.15
Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development. Cancer Immunol Immunother (2007) 1.15
Identification of filamin C as a new physiological substrate of PKBalpha using KESTREL. Biochem J (2004) 1.14
Directing noble metal ion chemistry within a designed ferritin protein. Biochemistry (2008) 1.12
Differential activation of p38MAPK isoforms by MKK6 and MKK3. Cell Signal (2009) 1.12
Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation. Mol Cell Biol (2011) 1.12
Crystal structure of lactaldehyde dehydrogenase from Escherichia coli and inferences regarding substrate and cofactor specificity. J Mol Biol (2006) 1.10
Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A. Cell Signal (2002) 1.10
Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis (2009) 1.09
In vitro and in vivo complementation of the Helicobacter pylori arginase mutant using an intergenic chromosomal site. Helicobacter (2006) 1.07
Structural and mechanistic analysis of trichodiene synthase using site-directed mutagenesis: probing the catalytic function of tyrosine-295 and the asparagine-225/serine-229/glutamate-233-Mg2+B motif. Arch Biochem Biophys (2007) 1.07
Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference. Clin Cancer Res (2007) 1.07
X-ray crystallographic studies of substrate binding to aristolochene synthase suggest a metal ion binding sequence for catalysis. J Biol Chem (2008) 1.07
Crystal structure of human arginase I complexed with thiosemicarbazide reveals an unusual thiocarbonyl mu-sulfide ligand in the binuclear manganese cluster. J Am Chem Soc (2007) 1.07
L-arginine deprivation regulates cyclin D3 mRNA stability in human T cells by controlling HuR expression. J Immunol (2010) 1.06
Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis. J Clin Invest (2012) 1.06
Structure of isoprene synthase illuminates the chemical mechanism of teragram atmospheric carbon emission. J Mol Biol (2010) 1.05
Expression, assay, and structure of the extracellular domain of murine carbonic anhydrase XIV: implications for selective inhibition of membrane-associated isozymes. J Biol Chem (2003) 1.04
Role of arginine-304 in the diphosphate-triggered active site closure mechanism of trichodiene synthase. Biochemistry (2005) 1.04
Association of interleukin-1beta gene polymorphisms with precancerous gastric lesions in African Americans and Caucasians. Am J Gastroenterol (2006) 1.04
Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. Int J Cancer (2013) 1.04
Structural and functional importance of first-shell metal ligands in the binuclear manganese cluster of arginase I. Biochemistry (2003) 1.04
Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis (2008) 1.03
Binding of uridine 5'-diphosphate in the "basic patch" of the zinc deacetylase LpxC and implications for substrate binding. Biochemistry (2006) 1.01
Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer. J Med Chem (2013) 1.00
Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with "two-prong" inhibitors reveal the molecular basis of high affinity. J Am Chem Soc (2006) 1.00
Expression, purification, assay, and crystal structure of perdeuterated human arginase I. Arch Biochem Biophys (2007) 0.98
Structure and catalytic mechanism of human steroid 5beta-reductase (AKR1D1). Mol Cell Endocrinol (2008) 0.98